Christopher Flynn

1.9k total citations · 1 hit paper
33 papers, 1.5k citations indexed

About

Christopher Flynn is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Christopher Flynn has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Christopher Flynn's work include Genetic factors in colorectal cancer (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Plant biochemistry and biosynthesis (4 papers). Christopher Flynn is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Plant biochemistry and biosynthesis (4 papers). Christopher Flynn collaborates with scholars based in United States, Australia and Iran. Christopher Flynn's co-authors include Claudia Schmidt‐Dannert, Maureen B. Quin, Huidong Yuan, Dianqing Wu, David Kimelman, Gist H. Farr, Junhao Mao, Li Lin, Weijun Pan and Shinji Takada and has published in prestigious journals such as Molecular Cell, Applied and Environmental Microbiology and Cancer Research.

In The Last Decade

Christopher Flynn

33 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low-Density Lipoprotein Receptor-Related Protein-5 Binds to Axin and Regulates the Canonical Wnt Signaling Pathway

2001 677 citations Junhao Mao, Jiyong Wang et al. Molecular Cell profile →

Peers

Countries citing papers authored by Christopher Flynn

Since Specialization

Citations

This map shows the geographic impact of Christopher Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Flynn more than expected).

Fields of papers citing papers by Christopher Flynn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Flynn. The network helps show where Christopher Flynn may publish in the future.

Co-authorship network of co-authors of Christopher Flynn

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Flynn. A scholar is included among the top collaborators of Christopher Flynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Flynn. Christopher Flynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fabrication of waveguide directional couplers using 2-photon lithography 2023 ·Optics Express ·Christopher Flynn, (unknown), Brian E. Applegate, Tomasz Tkaczyk	3
2	High-spatial density snapshot imaging spectrometer enabled by 2-photon fabricated custom fiber bundles 2023 ·Optics Letters ·(unknown), Christopher Flynn, Brian E. Applegate, Tomasz Tkaczyk	1
3	Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers 2023 ·Breast Cancer Research and Treatment ·(unknown), Paul Weisman, (unknown), (unknown), (unknown), (unknown), Christopher Flynn, Jin Xu	3
4	The Epithelial–Stromal Microenvironment in Early Colonic Neoplasia 2021 ·Molecular Cancer Research ·Takayasu Ideta, Boyang Li, Christopher Flynn, (unknown), Geoffrey Lowman, (unknown), Thomas J. Devers, John Birk, Faripour Forouhar, Charles Giardina, Daniel W. Rosenberg	4
5	HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma 2021 ·International Journal of Gynecological Pathology ·(unknown), (unknown), (unknown), (unknown), (unknown), Pei Hui, Natália Buza, Ahmed Al‐Niaimi, Christopher Flynn, Paul Weisman, Stephanie M. McGregor	20
6	High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability 2021 ·BMC Cancer ·Daniel R. Matson, Ryan A. Denu, Lauren M. Zasadil, Mark E. Burkard, Beth A. Weaver, Christopher Flynn, P. Todd Stukenberg	21
7	Expression of the Fusarium graminearum terpenome and involvement of the endoplasmic reticulum-derived toxisome 2019 ·Fungal Genetics and Biology ·Christopher Flynn, Karen Broz, Wilfried Jonkers, Claudia Schmidt‐Dannert, Harold Kistler	27
8	Fusarium toxisomes may be necessary for synthesis of high levels of deoxynivalenol and production of the distinct sesquiterpene mycotoxin, culmorin 2018 ·Phytopathology ·Christopher Flynn, Guangfei Tang, Marike Johanne Boenisch, A. Blum, Karen Broz, (unknown), Claudia Schmidt‐Dannert, Zhonghua Ma, (unknown)	2
9	Multiple concurrent unusual neoplasms presenting in a patient with familial adenomatous polyposis: A case report and review of the literature 2018 ·Human Pathology Case Reports ·(unknown), (unknown), Stephen L. Rose, Jennifer Laffin, William M. Rehrauer, Gaye Hafez, Christopher Flynn	1
10	Sesquiterpene Synthase–3-Hydroxy-3-Methylglutaryl Coenzyme A Synthase Fusion Protein Responsible for Hirsutene Biosynthesis in Stereum hirsutum 2018 ·Applied and Environmental Microbiology ·Christopher Flynn, Claudia Schmidt‐Dannert	28
11	Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer 2016 ·Clinical Cancer Research ·Kari B. Wisinski, Amyé Tevaarwerk, Mark E. Burkard, Murtuza Rampurwala, Jens C. Eickhoff, Maria C. Bell, Jill Kolesar, Christopher Flynn, Glenn Liu	42
12	Mushroom Hunting by Using Bioinformatics: Application of a Predictive Framework Facilitates the Selective Identification of Sesquiterpene Synthases in Basidiomycota 2013 ·ChemBioChem ·Maureen B. Quin, Christopher Flynn, Grayson T. Wawrzyn, Swati Choudhary, Claudia Schmidt‐Dannert	60
13	Basal cell adenocarcinoma arising in salivary gland metaplasia of the breast: a novel salivary gland–type tumor developing in the breast 2012 ·Human Pathology ·Christopher Flynn, Maryam Kadivar, (unknown), Mariella Bonzanini, G. Kenneth Haines, Fattaneh A. Tavassoli	5
14	Deoxycholic acid promotes the growth of colonic aberrant crypt foci 2006 ·Molecular Carcinogenesis ·Christopher Flynn, David C. Montrose, (unknown), Masako Nakanishi, Jillian N.M. Ilsley, Daniel W. Rosenberg	47
15	Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors 2006 ·Biochemical Pharmacology ·(unknown), Glenn S. Belinsky, Christopher Flynn, Emily J. Noonan, (unknown), Cassandra A. Godman, (unknown), Prashant R. Nambiar, Daniel W. Rosenberg, Charles Giardina	11
16	Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability 2004 ·Oncogene ·Kishore Guda, Madhvi B. Upender, Glenn S. Belinsky, Christopher Flynn, Masako Nakanishi, (unknown), Thomas Ried, Daniel W. Rosenberg	43
17	Murine models of ulcerative colitis 2003 ·Archives of Pharmacal Research ·Christopher Flynn, Joel B. Levine, Daniel W. Rosenberg	3
18	Low-Density Lipoprotein Receptor-Related Protein-5 Binds to Axin and Regulates the Canonical Wnt Signaling Pathway breakdown → 2001 ·Molecular Cell ·Junhao Mao, Jiyong Wang, Bo Liu, Weijun Pan, Gist H. Farr, Christopher Flynn, Huidong Yuan, Shinji Takada, David Kimelman, Li Lin, Dianqing Wu	677
19	Asymptomatic Lung Carcinoma Presenting with a Large Vulvar Lesion 2001 ·Journal of Lower Genital Tract Disease ·Brian C. Cooper, Thomas Buekers, Christopher Flynn, Joel I. Sorosky, Richard E. Buller	1
20	In VitroEfficacy of Levofloxacin Alone or in Combination Tested Against Multi-ResistantPseudomonas aeruginosaStrains 1996 ·Journal of Chemotherapy ·Christopher Flynn, David M. Johnson, Ronald N. Jones	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact